Jakob Dupont
2014 - OncoMed Pharmaceuticals
In 2014, Jakob Dupont earned a total compensation of $1.8M as Senior Vice President & Chief Medical Officer at OncoMed Pharmaceuticals, a 62% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $132,010 |
|---|---|
| Option Awards | $646,270 |
| Salary | $377,171 |
| Stock Awards | $620,600 |
| Total | $1,776,051 |
Dupont received $646.3K in option awards, accounting for 36% of the total pay in 2014.
Dupont also received $132K in non-equity incentive plan, $377.2K in salary and $620.6K in stock awards.
Rankings
In 2014, Jakob Dupont's compensation ranked 5,009th out of 13,032 executives tracked by ExecPay. In other words, Dupont earned more than 61.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,009 out of 13,032 | 62nd |
Division Manufacturing | 1,785 out of 4,966 | 64th |
Major group Chemicals And Allied Products | 589 out of 1,686 | 65th |
Industry group Drugs | 449 out of 1,365 | 67th |
Industry Pharmaceutical Preparations | 358 out of 1,043 | 66th |
Source: SEC filing on April 29, 2016.
Dupont's colleagues
We found two more compensation records of executives who worked with Jakob Dupont at OncoMed Pharmaceuticals in 2014.